RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients Corinne Merle 10.24376/rd.sgul.5831706.v1 https://sgul.figshare.com/articles/presentation/RAFA_Trial_Results_High_Dose_Rifampicin_Tuberculosis_treatment_regimen_to_reduce_12_month_mortality_of_TB_HIV_co-infected_patients/5831706 RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients - Corinne Merle.<br><br>This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting can be accessed from the link referenced below. 2018-02-05 17:02:04 TB INTERTB Tuberculosis Clinical Trials Rifampicin Treatment Results Global Health HIV Immunology Infectious Diseases Medicine Pharmacology